A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Clinical trial NCT04017962 · COMPLETED

Trial details

NCT number: NCT04017962
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

CMV CMV Infection Hematopoietic Cell Transplant

Start date: 2019-07-19
Primary completion: 2024-08-07
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.